• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2023年越南河内重症监护病房入院筛查中耐碳青霉烯类铜绿假单胞菌的基因组特征分析

Genomic characterization of carbapenem-resistant Pseudomonas aeruginosa from ICU admission screening in Hanoi, Vietnam, 2023.

作者信息

Göpel Lisa, My Truong Nhat, Kocer Kaan, Pham Thi Anh Mai, Linh Le Thi Kieu, Sy Bui Tien, Huber Leo, Tung Tran Thanh, The Nguyen Trong, Song Le Huu, Boutin Sébastien, Velavan Thirumalaisamy P, Nurjadi Dennis

机构信息

Institute of Medical Microbiology, University of Lübeck and University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany.

Vietnamese-German Centre for Medical Research (VG-CARE), Hanoi, Vietnam; 108 Military Central Hospital, Hanoi, Vietnam.

出版信息

J Glob Antimicrob Resist. 2025 Jul 7;44:265-271. doi: 10.1016/j.jgar.2025.07.002.

DOI:10.1016/j.jgar.2025.07.002
PMID:40633763
Abstract

OBJECTIVE

Vietnam is among the countries most affected by antimicrobial resistance in the Asia-Pacific. While multidrug-resistant Enterobacterales have been extensively studied, genomic data on multidrug-resistant Pseudomonas aeruginosa in Vietnam remains scarce. To address this, we characterized 20 carbapenem-resistant P. aeruginosa (CRPA) isolates from rectal colonization of ICU patients.

METHODS

Screening for CRPA was conducted using a selective chromogenic medium (mSuperCARBA). Species identification was achieved through MALDI-TOF mass spectrometry, while antimicrobial susceptibility testing was performed using the Vitek®2 system and broth microdilution. Whole-genome sequencing was performed using the Illumina NextSeq platform.

RESULTS

Twenty CRPA isolates were collected from rectal swabs of 691 patients admitted to the ICUs of the 108 Military Central Hospital in Hanoi, Vietnam, between 1 July 2023 and 31 October 2023. The predominant multilocus sequence type was ST308, accounting for 50% (10/20) of the isolates. Notably, 70% (14/20) of the CRPA isolates harboured genes encoding metallo-β-lactamases (MBL), with bla being the most prevalent (86%, 12/14), followed by bla (14%, 2/14). Low susceptibility was observed for ceftazidime-avibactam (15%, 3/20) and ceftolozane-tazobactam (10%, 2/20), while cefiderocol resistance was observed in 50% (10/20) of isolates. Colistin demonstrated the most favourable susceptibility profile, with 90% (18/20) of isolates remaining susceptible.

CONCLUSIONS

A significant proportion of CRPA isolates in our study were MBL producers, with high levels of resistance to novel β-lactams and β-lactam/β-lactamase inhibitor combinations. These findings underscore the urgent need for effective infection prevention and control strategies to mitigate the further spread of MBL-producing CRPA.

摘要

目的

越南是亚太地区受抗菌药物耐药性影响最严重的国家之一。虽然对多重耐药肠杆菌科细菌已有广泛研究,但越南多重耐药铜绿假单胞菌的基因组数据仍然匮乏。为解决这一问题,我们对20株来自重症监护病房(ICU)患者直肠定植的耐碳青霉烯类铜绿假单胞菌(CRPA)分离株进行了特征分析。

方法

使用选择性显色培养基(mSuperCARBA)进行CRPA筛查。通过基质辅助激光解吸电离飞行时间质谱(MALDI-TOF)进行菌种鉴定,同时使用Vitek®2系统和肉汤微量稀释法进行药敏试验。使用Illumina NextSeq平台进行全基因组测序。

结果

2023年7月1日至2023年10月31日期间,从越南河内108军事中心医院ICU收治的691例患者的直肠拭子中收集到20株CRPA分离株。主要的多位点序列类型是ST308,占分离株的50%(10/20)。值得注意的是,70%(14/20)的CRPA分离株携带编码金属β-内酰胺酶(MBL)的基因,其中bla最为常见(86%,12/14),其次是bla(14%,2/14)。头孢他啶-阿维巴坦(15%,3/20)和头孢洛扎坦-他唑巴坦(10%,2/20)的敏感性较低,而50%(10/20)的分离株对头孢地尔耐药。黏菌素显示出最有利的药敏情况,90%(18/20)的分离株仍敏感。

结论

我们研究中的很大一部分CRPA分离株是MBL产生菌,对新型β-内酰胺类药物和β-内酰胺/β-内酰胺酶抑制剂组合具有高水平耐药性。这些发现强调了迫切需要有效的感染预防和控制策略,以减轻产MBL的CRPA的进一步传播。

相似文献

1
Genomic characterization of carbapenem-resistant Pseudomonas aeruginosa from ICU admission screening in Hanoi, Vietnam, 2023.2023年越南河内重症监护病房入院筛查中耐碳青霉烯类铜绿假单胞菌的基因组特征分析
J Glob Antimicrob Resist. 2025 Jul 7;44:265-271. doi: 10.1016/j.jgar.2025.07.002.
2
Molecular characterization of metallo-beta-lactamase producers among carbapenem-resistant Pseudomonas aeruginosa from clinical samples in a tertiary care hospital, Lucknow, India.印度勒克瑙一家三级护理医院临床样本中耐碳青霉烯类铜绿假单胞菌产金属β-内酰胺酶菌株的分子特征分析
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 18. doi: 10.1007/s00210-025-03913-6.
3
Susceptibility toward cefiderocol and sulbactam-durlobactam in extensively drug-resistant detected from ICU admission screening in Hanoi, Vietnam, 2023.2023年在越南河内的重症监护病房入院筛查中检测到的广泛耐药菌对头孢地尔和舒巴坦-杜洛巴坦的敏感性。
Microbiol Spectr. 2025 Jul;13(7):e0083225. doi: 10.1128/spectrum.00832-25. Epub 2025 Jun 9.
4
Molecular study of carbapenem-resistant Pseudomonas aeruginosa causing wound infection in an Egyptian tertiary hospital.埃及一家三级医院中引起伤口感染的耐碳青霉烯类铜绿假单胞菌的分子研究。
J Infect Dev Ctries. 2025 Jul 28;19(7):997-1006. doi: 10.3855/jidc.19953.
5
Genomic dissection of nosocomial multiclonal-outbreak by carbapenem-resistant Pseudomonas aeruginosa strains in a tertiary children's hospital in Japan.日本一家三级儿童医院中耐碳青霉烯类铜绿假单胞菌菌株引起的医院内多克隆暴发的基因组剖析
J Glob Antimicrob Resist. 2025 Sep;44:89-94. doi: 10.1016/j.jgar.2025.05.026. Epub 2025 Jun 11.
6
The bacterial etiology and antimicrobial susceptibility of lower respiratory tract infections in Vietnam.越南下呼吸道感染的细菌病因及抗菌药敏情况
Ann Clin Microbiol Antimicrob. 2025 Aug 31;24(1):50. doi: 10.1186/s12941-025-00818-3.
7
ARGONAUT-III and -V: susceptibility of carbapenem-resistant and multidrug-resistant to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime.ARGONAUT-III 和 -V:碳青霉烯类耐药和多重耐药对双环硼酸β-内酰胺酶抑制剂替加环素与头孢吡肟联合用药的敏感性。
Antimicrob Agents Chemother. 2024 Sep 4;68(9):e0075124. doi: 10.1128/aac.00751-24. Epub 2024 Aug 12.
8
In vitro activity of cefepime-zidebactam, ceftolozane-tazobactam, ceftazidime-avibactam, imipenem-relebactam, and other comparators against imipenem-non-susceptible Pseudomonas aeruginosa in Taiwan, 2022.2022年台湾地区头孢吡肟-他唑巴坦、头孢托罗-他唑巴坦、头孢他啶-阿维巴坦、亚胺培南-瑞来巴坦及其他对照药物对亚胺培南不敏感铜绿假单胞菌的体外活性
Int J Antimicrob Agents. 2025 Sep;66(3):107550. doi: 10.1016/j.ijantimicag.2025.107550. Epub 2025 Jun 4.
9
Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23).加拿大医院耐碳青霉烯类铜绿假单胞菌的特征:CANWARD研究6年(2018 - 2023年)
J Antimicrob Chemother. 2025 Aug 28;80(Supplement_2):ii62-ii71. doi: 10.1093/jac/dkaf222.
10
Import of global high-risk clones is the primary driver of carbapenemase-producing in Norway.全球高危克隆株的引入是挪威产碳青霉烯酶菌株产生的主要驱动因素。
J Med Microbiol. 2025 Jan;74(1). doi: 10.1099/jmm.0.001944.